Business Context and Reporting Period
Company: Flexible Solutions International Inc. (FSI)
Filing Type: Form 10-Q (Unaudited)
Period Ended: June 30, 2026
Business Overview: FSI operates two primary segments: Specialty Chemicals (SPCH), which produces biodegradable polymers for oil/gas and agriculture, and Food Grade Products and Ingredients (FGPI). The company is incorporated in Alberta, Canada, and trades on the NYSE American under the symbol FSI.
Key Financial Metrics
| Metric | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Total Sales | $15,907,145 | $18,840,824 |
| Gross Profit | $1,601,540 | $7,336,830 |
| Operating Loss | $(2,307,071) | $3,227,957 (Income) |
| Net Loss | $(2,148,888) | $1,881,193 (Income) |
| Net Loss Attributable to FSI | $(2,154,387) | $1,751,178 (Income) |
| Cash from Operating Activities | $3,495,249 | $4,738,637 |
| Cash and Term Deposits | $7,850,595 | $8,011,898 |
| Total Debt (Current + Long Term) | $5,928,825 | $6,588,046 |
| Working Capital | $18,691,445 | $24,227,759 |
Material Changes vs. Prior Period
- Revenue Decline: Total sales decreased by approximately 15.6% year-over-year. This was driven by a lack of recurring Research and Development (R&D) service revenue ($2.5M in 2025 vs. $0 in 2026) and delays at the new Panama facility affecting SPCH product orders.
- Profitability Reversal: The company swung from a net income of $1.88M in the prior year to a net loss of $2.15M. Gross margin compression occurred due to startup costs, training, and higher utilities associated with scaling the new FGPI product line and the Panama facility.
- Investment Settlement: In June 2026, FSI settled a dispute with a Florida-based LLC (formerly an equity method investment). The company surrendered its 19.9% equity interest and forgave receivables in exchange for a perpetual, royalty-free license to market products in Latin America and the Caribbean. No gain or loss was recognized on the exchange.
- Customer Concentration: Three primary customers accounted for 55% of sales in the first six months of 2026, up from 47% in the prior year. A new FGPI customer represented 29% of total sales.
Outlook, Risks, and Management Commentary
- Operational Outlook: Management expects the margin compression related to the new FGPI product and Panama facility startup to taper off in Q3 2026. They anticipate recouping delayed SPCH orders later in 2026.
- Liquidity: The company reports sufficient cash resources to meet commitments for the coming year with no substantial cash outlays required. Working capital remains positive at $18.7M.
- Internal Controls: Management concluded that disclosure controls and procedures were ineffective as of June 30, 2026. Material weaknesses identified in 2025 regarding the financial statement close process are being remediated, with full implementation expected by Q4 2026.
- Risk Factors: Key risks include dependence on crude oil prices (for aspartic acid imports from China), activity in the oil and gas sector, drought conditions affecting agricultural sales, and potential new tariffs on Chinese raw materials.
Investor Verification Checklist
- Margin Sustainability: Verify if the "temporary" margin compression from the new FGPI line and Panama facility resolves in Q3 2026 as projected.
- Customer Concentration: Assess the risk associated with the new FGPI customer representing 29% of sales and the loss of the former R&D customer.
- Internal Control Remediation: Monitor the progress of the remediation plan for material weaknesses in internal controls over financial reporting.
- Inventory Levels: Review the increase in inventory from $10.5M to $15.1M to ensure it aligns with the new production capacity and sales demand.
- Debt Covenants: Confirm compliance with debt covenants, particularly the minimum ratio of qualifying financial assets to obligations required by the Stock Yards Bank line of credit.